Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia

Explore clinical trials studying Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

1,002 public trials 282 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia trial results

Active, Not Recruiting

A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML

NCT04730258

Conditions
AML, Acute Myeloid Leukemia, Bone Marrow Diseases, +19 more
Locations
  • City of Hope Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Norton Cancer Institute - Saint Matthews Louisville, Kentucky, United States
  • New York Presbyterian Weill Cornell Medical Center New York, United States
View Trial Details
Active, Not Recruiting

IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome

NCT03503409

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations
  • CH Angers Angers, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • Hôpital Nord Franche-Comté/Service de médecine interne / Hématologie clinique Belfort, France
  • CHU côte de Nacre Caen, France
View all 38 locations
View Trial Details
Active, Not Recruiting

A Study to Asses Effectiveness and Treatment Management of Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in Adult Participants Ineligible for Intensive Chemotherapy With de Novo Acute Myeloid Leukemia (AML) in Italy

NCT06058741

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Presidio Ospedaliero Vito Fazzi /ID# 261222 Lecce, Apulia, Italy
  • Azienda Ospedaliero Universitaria Careggi /ID# 259766 Florence, Firenze, Italy
  • Ospedale San Martino /ID# 258981 Genoa, Genova, Italy
  • IRCCS Istituto Clinico Humanitas /ID# 259300 Rozzano, Lombardy, Italy
View all 28 locations
View Trial Details
Active, Not Recruiting

MIF Involvement in AML

NCT03918655

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Laboratoire d'hématologie Hôpital Saint Antoine Paris, France
View Trial Details
Active, Not Recruiting

Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT

NCT04476199

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • USD, Trapianti di Midollo osseo, Azienda Spedali Civili di Brescia Brescia, Italy
  • Unità Terapia Intensiva Ematologica e terapia cellulari - casa della sofferenza San Giovanni Rotondo, Foggia, Italy
  • UO Ematologia e TMO - Ospedale C. Panico Tricase, Lecce, Italy
  • Ospedale San Gerardo Monza, Italy
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy

NCT04027309

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • AU-Adelaide-FLINDERS Adelaide, Australia
  • AU-Adelaide-RAH Adelaide, Australia
  • AU-Brisbane-PAH Brisbane, Australia
  • AU-Brisbane-RBWH Brisbane, Australia
View all 193 locations
View Trial Details

Related conditions